Big Pharma is going to have to acquire substantial products to replace what's expiring the next 5 years Top 10 drugs with patents due to expire in the next five years Hannah Burke 16/02/2024 10 drugs that will expire with a total of $200B in Revenue 1. KEYTRUDA Company: Merck & Co. Key patent expiration: 2028 2. ELIQUIS Company: Bristol Myers Squibb & Pfizer Key patent expirations: 2027 to 2029 3. EYLEA Company: Regeneron, Bayer Key patent expirations: 2025 to 2026 4. OPDIVO Company: Bristol Myers Squibb Key patent expiration: 2028 5. IBRANCE Company: Pfizer Key patent expiration: 2027 6. XARELTO Company: Bayer / J&J Key patent expiration: 2026 7. TRULICITY Company: Eli Lilly Key patent expiration: 2027 8. PREVNAR 13 Company: Pfizer Key patent expiration: 2026 9. OCREVUS Company: Roche Key patent expiration: 2028 10. PROLIA/XGEVA Company: Amgen Key patent expiration: 2025 to 2026 https://www.proclinical.com/blogs/2024-2/top-10-drugs-with-patents-due-to-expire-in-the-next-5-years#:~:text=Key%20patent%20expiration%3A%202028&text=Keytruda%20is%20on%20schedule%20to,%2433.7bn%20in%202028%20estimates.